Related to Bridges that Indian Biosimilar Makers Must Cross to Prosper in International Markets

• PerkinElmer Makes Two Acquisitions to Pad Diagnostics Business in Emerging Markets
  
• Wellcome Trust and Merck Set Up JV to Focus on Vaccines for Developing Nations
  
• Prodrug of Eisai’s Antifungal to Be Investigated in Chagas
  
• Sandoz Launches Somatropin Biosimilar in Japan
  
• Merck KGaA and Lonza Separately Acquire Indian Bioscience Companies
  
• Millipore Acquires Remaining Ownership of India JV
  
• GVK Biosciences Joins ResearchPoint Global’s Worldwide CRO Network
  
• PPD Continues Asia Expansion with Plans for New Facilities in the Philippines and India
  
• Teva Ponies Up €3.625B for Ratiopharm
  
• Invida to Commercialize Three Ipsen Drugs in Asia Pacific Countries
  
• Abbott Steps Up Presence in Emerging Markets through Deal with Zydus
  
• Abbott Boosts Presence in India with Acquisition of Generics Business for $3.72B
  
• Watson to Develop Itero’s Biosimilar for Treating Female Infertility
  
• ISCO Partners with IBVI to Set Up Indian Facility for Stem Cell Therapies
  
• Cellectis Taps Helix Biocon to Promote Cell-Line Engineering Services in India
  
• Biotools and Kilpest Form Indian JV to Develop Clinical and Molecular Biology Products
  
• ISCO and Insight Bioventures Sets Up Indian Affiliate
  
• PPD Inks Deal with HIHT University to Increase Network in Northern India
  
• Canadian and Indian Researchers Establish R&D Consortium to Tackle Malaria
  
• Cambrex Buys 51% of Zenara for $20M as First Stage in Overall Buyout of Indian Firm